CHAF1A and breast carcinoma: Elevated expression of CHAF1A was significantly correlated with shorter overall survival (OS) (Figure 2F), shorter recurrence free survival (RFS) (Figure 2G), and shorter distant metastasis free survival (DMFS) (Figure 2H) of breast cancer patients obtained from Kaplan-Meier plotter (Győrffy, 2021) survival analysis.